Home Endo to pay $25M for nasal testosterone replacement therapy
 

Keywords :   


Endo to pay $25M for nasal testosterone replacement therapy

2014-11-25 00:20:24| Biotech - Topix.net

Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million. Natesto is the only testosterone nasal gel approved by the Food and Drug Administration as a replacement therapy for adult males with hypogonadism - a condition where sex glands produce little or no sex hormones.

Tags: pay therapy replacement 25m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06Atlantic Tropical Weather Outlook
31.05Vytelle expands to Melbourne, Australia with its 21st global bovine IVF lab
31.05USDA celebrates 100 years of agriculture innovation
31.05Bob Pasquale elected president of ARC
31.05Eastern North Pacific Tropical Weather Outlook
More »